Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermoxyl is a **non-specific brand name** that appears to have been used for multiple distinct pharmaceutical and hygiene products rather than a single uniquely identifiable drug. Based on the provided context, it has referred at least to a **topical benzoyl peroxide** preparation used for acne vulgaris and leg ulcers, a **terbinafine hydrochloride** antifungal product marketed in oral tablet and topical cream forms for dermatophyte and yeast infections including tinea and onychomycosis, and a **skin cleansing disinfectant solution**. Because these products differ in active ingredient, mechanism, dosage form, route, and indication, Dermoxyl cannot be annotated as one precise molecular entity without additional product-specific context such as country, manufacturer, strength, or formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermoxyl.